• Return to Headlines

Shares of Vertex Pharm Rise to a New 52-Week High

By James Quinn

Vertex Pharm (NASDAQ:VRTX) traded today at a new 52-week high of $199.49. Approximately 219,000 shares have changed hands today, as compared to an average 30-day volume of 938,000 shares.

Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis.

Vertex Pharm (NASDAQ:VRTX) is currently priced 3.1% above its average consensus analyst price target of $191.59. The stock should find initial support at its 200-day moving average (MA) of $178.84 and further support at its 50-day MA of $177.76.

In the past 52 weeks, Vertex Pharm share prices have been bracketed by a low of $151.80 and a high of $199.49 and are now at $197.77, 30% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.4%.

SmarTrend is monitoring the recent change of momentum in Vertex Pharm. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Vertex Pharm in search of a potential trend change.

Keywords: 52 week high/lows vertex pharm

Ticker(s): VRTX